Cellebrite to Acquire Corellium for $170 Million

The latest update is out from Cellebrite DI ( (CLBT) ).

On June 5, 2025, Cellebrite announced its agreement to acquire Corellium, a leader in Arm-based virtualization software, for $170 million. This acquisition is expected to enhance Cellebrite’s digital investigation capabilities and broaden its market reach in both public and private sectors, particularly benefiting customers in defense, intelligence, and development of secure mobile applications and IoT devices.

The most recent analyst rating on (CLBT) stock is a Buy with a $24.00 price target. To see the full list of analyst forecasts on Cellebrite DI stock, see the CLBT Stock Forecast page.

Spark’s Take on CLBT Stock

According to Spark, TipRanks’ AI Analyst, CLBT is a Neutral.

Cellebrite DI’s stock score reflects its robust revenue growth and operational improvements, balanced by profitability challenges. The company’s strong cash flow generation supports operational stability, which is positive. Technical analysis indicates bearish trends, but potential for a rebound exists. Valuation remains a concern due to negative net income. The recent earnings call highlights strong product growth and optimism for future performance, boosting investor confidence.

To see Spark’s full report on CLBT stock, click here.

More about Cellebrite DI

Cellebrite DI Ltd. is a global leader in digital investigative solutions for both public and private sectors. The company specializes in AI-powered digital investigation platforms that allow lawful access, collection, analysis, and sharing of digital evidence, serving thousands of public safety organizations, intelligence agencies, and businesses worldwide.

Average Trading Volume: 1,221,794

Technical Sentiment Signal: Hold

Current Market Cap: $3.99B

Find detailed analytics on CLBT stock on TipRanks’ Stock Analysis page.